Drug Trial Radar · NCT03100942
Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome
Last checked: Nov 20, 2026Latest source record: Oct 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
152
Actual
Start
May 1, 2017
Primary completion
Jan 10, 2019
Study completion Oct 2, 2019
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- Collaborators
- Lakefront Biotherapeutics NV; Ono Pharmaceutical Co., Ltd.
- First posted
- Apr 4, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the efficacy of filgotinib, lanraplenib, and tirabrutinib in adults with active Sjogren's Syndrome (SjS).
Conditions
- Sjogren's Syndrome
Interventions
LanraplenibDrug
1 x 30 mg tablet administered orally once daily
FilgotinibDrug
1 x 200 mg tablet administered orally once daily
TirabrutinibDrug
1 x 40 mg tablet administered orally once daily
Lanraplenib placeboDrug
1 x tablet administered orally once daily
Filgotinib placeboDrug
1 x tablet administered orally once daily
Tirabrutinib placeboDrug
1 x tablet administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Fulfilling Protocol-Specified Response Criteria at Week 12, as Compared to BaselineTime frame: Week 12
Locations
53 sites in 4 countries. Site status is shown where the registry gives one.
AARR Arizona Arthritis & Rheumatology Research
Mesa, Arizona
AARR Arizona Arthritis & Rheumatology Research
Phoenix, Arizona
Medvin Clinical Research
Covina, California
Inland Rheumatology Clinical Trials, Inc.
Upland, California
Denver Arthritis Clinic
Denver, Colorado
Clinical Research of West Florida, Inc.
Clearwater, Florida
Omega Research Consultants LLC
DeBary, Florida
Center for Rheumatology Immunology and Arthritis
Fort Lauderdale, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
IRIS Research and Development, LLC
Plantation, Florida
North Georgia Rheumatology Group, PC
Lawrenceville, Georgia
Springfield Clinic
Springfield, Illinois
Center for Arthritis & Osteoporosis
Elizabethtown, Kentucky
June DO, PC
Lansing, Michigan
North Mississippi Medical Clinics, Inc. - Clinical Research
Tupelo, Mississippi
Clayton Medical Associates
St Louis, Missouri
Physician Research Collaboration, LLC
Lincoln, Nebraska
Albuquerque Clinical Trials
Albuquerque, New Mexico
Joint and Muscle Research Institute
Charlotte, North Carolina
Cape Fear Arthritis Care, PLLC
Leland, North Carolina
PMG Research of Salisbury
Salisbury, North Carolina
East Penn Rheumatology Associates, P.C.
Bethlehem, Pennsylvania
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Clinical Research Center of Reading, LLC
Wyomissing, Pennsylvania
ClinSearch
Chattanooga, Tennessee
Ramesh C. Gupta, MD
Memphis, Tennessee
Diagnostic Group Integrated Healthcare System, Pllc
Beaumont, Texas
Accurate Clinical Research Inc.
Houston, Texas
Southwest Rheumatology Research
Mesquite, Texas
Trinity Universal Research Associates
Plano, Texas
Arthritis & Osteoporosis Clinic
Waco, Texas
Wasatch Peak Family Practice
Layton, Utah
The Center for Arthritis and Rheumatic Diseases, PC
Chesapeake, Virginia
Arthritis Northwest
Spokane, Washington
Centrum Kliniczno-Badawcze
Elblag, Poland
Intermedius
Kościan, Poland
Centrum Badan Klinicznych S.C
Poznan, Poland
Ai Centrum Medyczne
Poznan, Poland
Centrum Medyczne Amed Warszawa Targowek
Warsaw, Poland
Centrum Medyczne Oporow
Wroclaw, Poland
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.